The effects of the SDF1-3 0 A on AIDS progression have been attributed to the altered amount of stromal cell-derived factor 1 (SDF-1). However, the contribution of the SDF1-G801A polymorphism to SDF-1 expression is still unclear. In contrast to fresh peripheral blood mononuclear cells (PBMCs), Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCLs) express the SDF-1 mRNA. Using EBV-transformed LCLs from 42 individuals with different genotypes, we investigated the SDF-1 mRNA levels and methylation status in the SDF1 gene. Both in PBMCs and in EBV-transformed LCLs, CpG dinucleotides in the 5 0 region of the SDF1 gene were unmethylated. As for the 3 0 untranslated region (3 0 UTR), by contrast, CpG dinucleotides were methylated in PBMCs, whereas site-specific demethylation around the polymorphic site was detected in EBV-transformed LCLs. The levels of the demethylation were correlated with the SDF-1 mRNA levels. However, the genotype for the SDF1-G801A polymorphism did not significantly alter the SDF-1 mRNA levels. The allele preferences in transcription and methylation were also absent in the heterozygous cells. In conclusion, this study suggested a contribution of site-specific demethylation in the 3 0 UTR to the SDF1 gene expression, but did not show any evidence for the contribution of the SDF1-G801A polymorphism to the amount of the SDF-1 mRNA.
Introduction
Stromal cell-derived factor 1 (SDF-1) is a CXC chemokine that plays important roles in embryonic development, hematopoiesis and chemoattraction. [1] [2] [3] Being a ligand for CXCR4, which is one of the coreceptors for human immunodeficiency virus-1 (HIV-1), 4 SDF-1 can be a competitor against the T-cell tropic HIV-1. 5, 6 Therefore, biological properties of SDF-1 have been thought to be involved in acquired immunodeficiency syndrome (AIDS) progression. An epidemiological study on HIV-1 carriers and AIDS patients has nominated a variant allele of the SDF1 gene, SDF1-3 0 A, as an AIDS-resistant allele. 7 The SDF1 gene has two transcriptional splice variants, SDF-1a and SDF-1b. 8 A transition, G-to-A, of the SDF1-3 0 A is located at nucleotide position (np) 801 in the 3 0 untranslated region (3 0 UTR) of the SDF-1b transcript ( Figure 1 ). Since this polymorphism, SDF1-G801A, does not result in amino-acid substitution of the SDF-1b protein, the effects of the SDF1-3 0 A allele on AIDS progression have been supposed to exert through the increased levels of SDF-1 expression. 7 However, recent retrospective studies concluded that the SDF1-3 0 A allele has no association with AIDS progression 9 or an association with accelerated AIDS progression. 10 Moreover, an in vitro study has suggested that SDF-1 not only inhibits infection of the HIV-1 but also enhances replication of the virus. 11 These pleiotropic effects of SDF-1 on HIV-1 may have concealed the in vivo effect of the SDF1-3 0 A allele. To study relations between the SDF1-G801A polymorphism and SDF-1 expression, transfection experiments have been performed but they have denied the effect of the SDF1-3 0 A. 12 However, this kind of experiments does not realize the original genome conditions of the transfected gene. For instance, status of DNA methylation, one of the regulatory factors in gene expression, 13, 14 would not be identical in the chromosomes and in the transfected vectors. To shed light on the relation of the SDF1-G801A polymorphism with gene expression, cells from a number of individuals with different genotypes are thus required.
Recently, it has been reported that infection of human T-cell leukemia virus-1 (HTLV-1) leads lymphocytes to express the SDF-1 mRNA. 15 Since we have observed that Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCLs) also express the SDF-1 mRNA, we have established an in vitro system to evaluate the levels of SDF1 gene expression in this study. Using this system, we studied (1) methylation status in the 5 0 region and the 3 0 UTR of the SDF1 gene, (2) difference in the SDF-1 mRNA expression levels among the SDF1-G801A genotypes and between the alleles, (3) relation between the SDF-1 mRNA levels and the methylation levels in the 3 0 UTR, and (4) effect of the SDF1-G801A polymorphism on the methylation levels in the 3 0 UTR of the SDF1 gene.
Results
Expression of the SDF-1 mRNA in EBV-transformed LCLs EBV-transformed LCLs expressed the SDF-1 mRNA in contrast to the fresh peripheral blood mononuclear cells (PBMCs) (Figure 2 ).
Methylation status in the 5 0 region and the 3 0 UTR of the SDF1 gene Using the bisulfite treatment and polymerase chain reaction (PCR)-direct sequencing, we observed that 70 CpG dinucleotides in the 5 0 region (5 0 flanking region, exon1 and intron1) of the SDF1 gene were unmethylated both in fresh PBMCs and in EBV-transformed LCLs (n ¼ 2) (Figure 3 ). This finding was confirmed by the restriction nuclease treatments; the PCR products were not digested by AccII and HpyCH4IV that cleave the bisulfite-modified sequence from methylated DNA.
Examining 12 CpG dinucleotides in the 3 0 UTR, we found that they were highly methylated in fresh PBMCs (n ¼ 2). In EBV-transformed LCLs (n ¼ 6), by contrast, site-specific demethylation of the CpG dinucleotides was observed around the polymorphic site ( Figure 3) .
Effect of the SDF1-G801A genotype on the SDF-1 mRNA levels in EBV-transformed LCLs Levels of the SDF-1 mRNA in the EBV-transformed LCLs showed much variation (Figure 4a and b) . In cells with
A, the levels of the SDF-1a mRNA (mean 7 95% confidential interval) were 1.00 7 0.37, 0.83 7 0.35 and 1.31 7 0.60, and those of the SDF-1b mRNA were 1.00 7 0.40, 0.79 7 0.33 and 1.33 7 0.57, respectively. These genotypes showed no significant difference in the levels of the SDF-1a and b mRNA (Kruskal-Wallis, P40.05). As shown in Figure 4c , we observed a correlation between the SDF-1a and b mRNA levels (r ¼ 0.882, Po0.0001). Correlation of the methylation levels in the 3 0 UTR with the genotype and the mRNA levels We measured methylation levels of the CpG dinucleotide at np 911-912 in the 3 0 UTR by applying an HpyCH4IV treatment to the bisulfite-modified sequence and compared them among the genotypes. As shown in Figure  5a , the genotypes did not significantly alter the methylation levels (Kruskal-Wallis, P40.05). As for the SDF-1 mRNA levels, they were inversely correlated with the methylation levels of the CpG dinucleotide (SDF-1a: r ¼ À0.580, Po0.0001; SDF-1b: r ¼ À0.618, Po0.0001) (Figure 5b ). 0 A to the SDF1-3 0 G in the AvaI-treated DNA was identical to that in the untreated DNA (Figure 6c ). This means that there was no allele preference in the methylation of the 3 0 UTR.
Preferential allele in transcription in

Discussion
As SDF-1 has multiple functions, 1-3 the SDF1-G801A polymorphism has been studied from different aspects to date. Besides the concern with AIDS progression, it has been suggested that the SDF1-3 0 A increases the levels of CD34 + progenitor cells mobilized into peripheral blood, 16 and has a relation with an early onset of type I diabetes. 17 Although the effects of the SDF1-3 0 A have been attributed to the alteration of the amount of SDF-1, participation of the polymorphism in SDF-1 expression SDFI-G801A and SDFI gene expression R Kimura et al has been still unclear and awaited to be revealed. Since PBMCs do not express SDF-1, it was difficult to obtain SDF-1-expressing cells from a number of individuals. In this study, we have shown that EBV-transformed LCLs express the SDF-1 mRNA. Since we can easily establish EBV-transformed LCLs, they provide a useful model to evaluate the SDF-1 mRNA levels in vitro.
The EBV latent proteins modify expression status of a number of cellular genes putatively through the regulation of transcription factors such as Rel/NF-kB, STAT1, and ETS proteins. 18 Expression of the SDF-1 mRNA in EBV-transformed LCLs would be mediated by these factors. Interestingly, expression of apoptosis inhibitors and proapoptotic factors is up-and downregulated, respectively, under EBV transformation, 18 and an SDF-1 exposure also leads lymphocytes to survive by inhibiting apoptosis. 19, 20 Recent studies have demonstrated that the SDF-1 RNA is expressed in T-cells transformed by HTLV-1 15 that causes adult T-cell leukemia and other chronic inflammatory diseases, and that children with AIDSrelated non-Hodgkin's lymphoma have higher levels of SDF-1 mRNA in PBMCs than those without lymphoma. 21 Since infection of EBV can cause several types of lymphoma, SDF-1 expression in lymphocytes may partly participate in the cell survival through paracrine and/ or autocrine manner, which can be a trigger for lymphomagenesis.
DNA methylation is one of the factors that regulate transcription in the mammalian genome. It has been suggested that methylation of cytosine in CpG dinucleotides in the 5 0 and the 3 0 flanking region represses gene expression by preventing transcription factors from binding to their target. 13, 22, 23 In this study, we observed that the 5 0 region of the SDF1 gene was unmethylated even in PBMCs where the SDF1 gene was not expressed. As for the 3 0 UTR of the SDF1b gene, by contrast, we found site-specific demethylation in the region around the polymorphic site at np 801 in the EBV-transformed LCLs that express the SDF-1 mRNA. In addition, we demonstrated that the levels of demethylation in the 3 0 UTR are correlated with the levels of the SDF-1 mRNAs. While mechanisms of site-specific demethylation are poorly understood, recent studies suggested that protein binding to a certain DNA sequence during DNA replication specifies sites of DNA demethylation by inhibiting remethylation of the replicated strand. [24] [25] [26] Therefore, it is conceivable that certain sequences in the 3 0 UTR play critical roles in the site-specific demethylation and SDF1 gene expression.
Since the G-to-A transition of the SDF1-3 0 A at np 801 results in a loss of a methylation site, the site-specific demethylation reminds us of the involvement of this transition in the expression levels of the SDF-1 mRNA. However, we did not observe any significant difference in the SDF-1 mRNA levels among LCLs with different genotypes. Both the alleles were equally expressed in the heterozygous LCLs. Moreover, the presence of the SDF1-G801A polymorphism in the SDF-1b mRNA did not alter the ratio of the SDF-1b mRNA to the SDF-1a mRNA. Taken together, these results indicate that the SDF1-G801A polymorphism affects neither transcription nor post-transcriptional factors that can alter the amount of SDF-1b mRNA, such as alternative splicing and mRNA stability.
The correlation between SDF1 gene expression and demethylation in the 3 0 UTR implies that the demethylation level, that is, the proportion of demethylated genes, corresponds to the proportion of cells expressing the SDF-1 mRNA in each cell line. Therefore, the variation of the SDF-1 mRNA levels among the LCLs would be in part due to the difference in the proportion of the cells expressing the SDF1 gene. In the meantime, absence of the allele preference in methylation of the CpG dinucleotides in the 3 0 UTR suggests that the SDF1-G801A polymorphism does not influence the susceptibility to demethylation in the 3 0 UTR. This confirms that this polymorphism plays no substantial roles in the activation of SDF1 gene expression.
Our in vitro system using EBV-transformed LCLs exhibited important findings; there was a significant correlation between demethylation in the 3 0 UTR and SDF1 gene expression, but no evidence for the association of the SDF1-G801A polymorphism with the amount of the SDF-1 mRNA. Although this system is useful to evaluate the SDF-1 expression levels, it may not exactly represent the in vivo situation of the SDF1 gene. To know more about the mechanism of SDF-1 expression, analyses using several types of cells from a number of individuals SDFI-G801A and SDFI gene expression R Kimura et al may be necessary, and effect of the polymorphism on translation efficiency of the SDF-1 protein remains to be elucidated. Alternatively, it could be argued that unknown polymorphisms linked with the SDF1-3 0 A are involved in the expression levels of SDF-1 and the AIDS progression. A variety of the SDF-1 mRNA levels among the LCLs in the present study may also result from other polymorphisms, if any, and EBV-transformed LCLs may contribute to identifying such polymorphisms.
Materials and methods
Samples
Blood samples were obtained from healthy volunteers after informed consent had been given. PBMCs were separated from the blood samples by Ficoll-Paque (Amersham Pharmacia Biotech, Uppsala, Sweden) density-gradient centrifugation and transformed by B95-8 strain of EBV. 27 We used a total of 42 LCLs (14 each of
A genotype) to evaluate the SDF-1 mRNA levels. These samples had been genotyped for the SDF1-G801A polymorphism by PCR-restriction fragment length polymorphism (RFLP) assay. 28 RNA and DNA extraction Fresh PBMCs and LCLs cultured for 8 weeks after virus infection were subjected to RNA and DNA extraction. Total RNAs were extracted from 5 Â 10 6 cells by using GenElute Mammalian Total RNA Kit (Sigma, St Louis, MO, USA) according to the manufacturer's instructions. Genomic DNAs were extracted by the standard phenolchloroform method.
Quantitative RT-PCR for the SDF-1 mRNA levels The total RNA samples were reverse-transcribed at 501C for 1 h by TrueScriptII Reverse Transcriptase (Sawady Technology, Tokyo, Japan) with the oligo dT primer. The relative amounts of the cDNAs for b-actin, SDF-1a and SDF-1b were measured by the real-time PCR using a LightCycler (Roche Diagnostics, Tokyo, Japan). PCR conditions were an initial denaturation at 951C for 10 min and a thermal cycling of 941C for 15 s, 681C for 10 s and 721C for 12 s. The following sequences of the specific primers were used in these PCRs: b-actin, bactinU
. We constructed these primer sets to span an intron so as to distinguish amplification of the cDNA sequences from that of genomic DNA sequences. Relative amounts of the SDF-1 mRNAs were standardized by that of the b-actin mRNA. Then, the mean value of the relative amounts in the SDF1-3 0 G/3 0 G homozygotes was set at one to be compared with that in the other genotypes.
Bisulfite treatment and PCR-direct sequencing Sodium bisulfite treatment of DNA was performed as described. 29 The bisulfite-modified DNA was subjected to PCR amplification using Ampli Taq Gold (Applied Biosystems, Foster City, CA, USA). For the bisulfitemodified sequence of a CpG island in the 5 0 region including 5 0 flanking region, exon1, and intron1 of the SDF1 gene, the following primer set spanning 70 CpG dinucleotides was used: bmSDF-239U (5 0 -GGAT GGGGTGGGGGGTGT) and bmSDF243L (5 0 -CTCTCTA-CAAATCACAAACCCTC-3 0 ). As for the 3 0 UTR of the SDF1 gene, we used two primer sets spanning 12 CpG dinucleotides in total: bmSDFb376U (5 0 -AAACCCCAAA-CATTACCAAAAACTTTAT-3 0 ) and bmSDFb916L (5 0 -GATGATGGATGAGATAGAGAATGAT GAGTA-3 0 ), and bmSDFb704U (5 0 -CAACCTAAACAAAACCTAATAAAA ACTTCT-3 0 ) and bmSDFb1354L (5 0 -AAGGTATTGA-TATGTGAGGGAGTATTGATG-3 0 ). The conditions for the PCRs were an initial denaturation at 951C for 9 min, 40 cycles of 941C for 30 s, 581C for 30 s and 721C for 1 min, and an additional extension at 721C for 5 min in the last cycle. Subsequently, we sequenced the PCR products by an ABI310 genetic analyzer (Applied Biosystems) using BigDye Terminator Cycle Sequencing Ready Reaction kit (Applied Biosystems). Methylation status of CpG dinucleotides was determined by sequencing signals.
Measurement of methylation levels using restriction nucleases
The PCR products from the bisulfite-modified sequence of the 5 0 region have one and 11 recognition site(s) for HpyCH4IV (New England Biolabs, Beverly, MA, USA) and AccII (Takara), respectively, when the CpG dinucleotides in these sites were methylated. When the CpG dinucleotides were unmethylated, by contrast, the PCR products have no recognition site for them. The reactions were performed at 371C for overnight. After 9% polyacrylamide gel electrophoresis (PAGE), the fragments were visualized by the ethidium bromide staining.
To measure the levels of methylation in the 3 0 UTR of the SDF1 gene, we performed another PCR amplification of the bisulfite-modified sequence using bmSDFb704U and bmSDFb916L primers. The PCR products were then treated with HpyCH4IV. When the cytosine in the CpG dinucleotide at np 911-912 is methylated, the PCR products (242 bp) are digested to be 208 and 34 bp fragments. The digested (208 bp) and undigested (242 bp) fragments were separated by 9% PAGE and stained by ethidium bromide. After analyzing the gel images, we calculated the proportion of methylated and unmethylated sequence. These measurements were duplicated.
Measurement of the ratio of the alleles in RNA and methylated DNA Total RNA samples derived from 14 LCLs with SDF1-3 0 G/3 0 A heterozygous genotype were subjected to the RT-PCR with One step RNA PCR kit (Takara, Shiga, Japan). An SDF-1b mRNA-specific primer set, SDF68U and SDFb955L (5 0 -GGCCATGGAGACAGTCGTG-3 0 ), was designed to span the polymorphic site and introns. Following reverse transcription at 501C for 30 min and denaturation at 941C for 2 min, amplifications were performed by 30 times of thermal cycling at 941C for 1 min and at 681C for 1 min. The last cycle was followed by a final extension step at 721C for 5 min. These products were then amplified by the seminested PCR using a primer set, SDFb266U (5 0 -AGAGGTTCAA-GATGTGAGAGG-3 0 ) and SDFb955L. The conditions for the PCR were 941C for 9 min, 40 cycles of 941C for 1 min and 701C for 1 min, and 721C for 5 min.
SDFI-G801A and SDFI gene expression R Kimura et al
DNAs from 14 LCLs with the SDF1-3 0 G/3 0 A heterozygous genotype were treated with a methylationsensitive restriction nuclease, AvaI (New England Biolabs). Since the CpG dinucleotide at np 890-891 in the 3 0 UTR is located in a recognition sequence of AvaI, DNA unmethylated at this site is digested by the nuclease, but methylated DNA is not (Figure 6b) . Then, the AvaI-treated DNA and untreated DNA were subjected to the PCR using SDFb266U and SDFb955L primers.
These RT-PCR and PCR products were treated with MspI (Toyobo, Osaka, Japan) that cleaves the sequence of the SDF1-3 0 G allele. The fragments were separated by 9% PAGE and stained by ethidium bromide. We analyzed the intensity of the bands and calculated the ratio of the SDF1-3 0 A (undigested: 708 bp) to the SDF1-3 0 G (digested: 535 bp) in the RNA and in the AvaI-treated DNA, regarding the mean value of the ratios in the untreated DNA as 1 : 1.
Analyses of gel images
For the scanning of gel images, we used a Printgragh (Atto, Tokyo, Japan). The relative amounts of the restriction fragments were determined densitometrically by the use of a software Kodak Digital Science 1D (Kodak, Rochester, NY, USA).
